Market Movers | Winners: WLTH, SWKS, ANGX | Losers: NAVN, RWT, EIKN
A day of broad market declines still produced sharp, divergent moves in individual stocks, raising questions about which shifts have staying power.
The day’s biggest winner, Wealthfront (WLTH), gained +15.0% while the biggest loser, Navan (NAVN), fell 21.7%. This happened against a backdrop of modest index declines, with the S&P 500 and the Dow Jones Industrial Average both returning -0.6% and the Nasdaq-100 returning -1.1%. The day’s extremes show how single-stock stories can run opposite the tape.
Thursday’s Market Winners
The 10 stocks in the Trefis coverage universe with the highest returns on the last trading day:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | WLTH | Wealthfront | 15.0% | -19.9% |
| 2 | SWKS | Skyworks Solutions | 9.8% | 35.3% |
| 3 | ANGX | Angel Studios | 9.1% | 15.2% |
| 4 | CLOV | Clover Health Investments | 8.5% | 100.4% |
| 5 | SPTX | Seaport Therapeutics | 7.0% | n/a |
| 6 | TYRA | Tyra Biosciences | 7.0% | -10.5% |
| 7 | QRVO | Qorvo | 6.8% | 33.0% |
| 8 | APPS | Digital Turbine | 6.7% | 136.0% |
| 9 | OBIO | Orchestra BioMed | 6.6% | 40.0% |
| 10 | GBLI | Global Indemnity | 6.5% | 6.7% |
Thursday’s Market Losers
And the 10 stocks with the lowest returns:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | NAVN | Navan | -21.7% | 18.6% |
| 2 | RWT | Redwood Trust | -14.8% | -29.6% |
| 3 | EIKN | Eikon Therapeutics | -14.2% | n/a |
| 4 | AXGN | Axogen | -11.5% | 27.9% |
| 5 | COAG | Hemab Therapeutics | -10.4% | n/a |
| 6 | CYPH | Cypherpunk Technologies | -10.2% | 89.7% |
| 7 | TGB | Trekor Metals | -10.2% | 41.7% |
| 8 | HLLY | Holley | -10.0% | -36.6% |
| 9 | ORBS | Eightco | -9.8% | -45.8% |
| 10 | FBYD | Falcons Beyond Global | -9.8% | -55.8% |
Today’s big moves are new stories.
No stock appears on both the one-day and one-month leaderboards. This suggests the day’s sharpest moves are fresh, not continuations of longer-term trends. The day’s top gainer, Wealthfront (WLTH), has a market value of about $1.7 billion and saw its revenue grow 14.1% over the last twelve months. The day’s weakest performer, Navan (NAVN), has a market value of about $5.1 billion.
Movers Over The Last Week
Widening the window to five trading days, these are the strongest and weakest Market names:
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | TTRX | Turn Therapeutics | 38.4% | 239.6% |
| 2 | IRD | Opus Genetics | 36.4% | 202.0% |
| 3 | CYPH | Cypherpunk Technologies | 31.0% | 89.7% |
| 4 | DOCN | DigitalOcean | 25.0% | 172.3% |
| 5 | SEI | Solaris Energy Infrastructure | 21.6% | 40.1% |
| 6 | WLTH | Wealthfront | 20.8% | -19.9% |
| 7 | APPS | Digital Turbine | 20.7% | 136.0% |
| 8 | ANGX | Angel Studios | 19.8% | 15.2% |
| 9 | ROIV | Roivant Sciences | 19.8% | 88.7% |
| 10 | MNTK | Montauk Renewables | 19.7% | 52.7% |
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | RARE | Ultragenyx Pharmaceutical | -45.7% | -37.4% |
| 2 | TTAN | ServiceTitan | -39.2% | -47.4% |
| 3 | GWRE | Guidewire Software | -27.3% | -30.3% |
| 4 | DYN | Dyne Therapeutics | -26.7% | -5.8% |
| 5 | MEI | Methode Electronics | -24.9% | 108.2% |
| 6 | NAVN | Navan | -24.7% | 18.6% |
| 7 | TBBK | Bancorp | -24.3% | -25.5% |
| 8 | CABA | Cabaletta Bio | -23.2% | 25.1% |
| 9 | PATH | UiPath | -22.9% | -15.4% |
| 10 | OCGN | Ocugen | -22.3% | -24.1% |
Movers Over The Last Month
And over the last 21 trading days:
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | CYPH | Cypherpunk Technologies | 223.5% | 89.7% |
| 2 | MRNA | Moderna | 125.6% | 363.3% |
| 3 | CAPR | Capricor Therapeutics | 111.2% | -71.2% |
| 4 | ARCT | Arcturus Therapeutics | 85.9% | 128.1% |
| 5 | PURR | Hyperliquid Strategies | 67.6% | 209.3% |
| 6 | ARX | Accelerant | 58.5% | 21.3% |
| 7 | IRD | Opus Genetics | 56.4% | 202.0% |
| 8 | AVAH | Aveanna Healthcare | 54.9% | 69.6% |
| 9 | HTFL | HeartFlow | 54.0% | 56.1% |
| 10 | FWDI | Forward Industries | 50.9% | -2.3% |
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | EYPT | EyePoint | -67.4% | -76.7% |
| 2 | ALMS | Alumis | -61.0% | 1.4% |
| 3 | RARE | Ultragenyx Pharmaceutical | -46.6% | -37.4% |
| 4 | KRMN | Karman | -44.5% | -53.0% |
| 5 | AADX | Applied Aerospace & Defense | -44.0% | n/a |
| 6 | BTQ | BTQ Technologies | -38.6% | -46.9% |
| 7 | AEVA | Aeva Technologies | -37.8% | 12.7% |
| 8 | LCID | Lucid | -37.6% | -60.5% |
| 9 | TTAN | ServiceTitan | -36.6% | -47.4% |
| 10 | DKS | Dick’s Sporting Goods | -35.7% | -32.6% |
A movers list is a map of attention, not a set of instructions.
The tables earlier in this report show performance over one week and one month, horizons that often tell a different story than a single day’s trading. A large move flags a stock where risk and attention are suddenly concentrated. The disciplined next step is not to chase the performance but to investigate the business behind the ticker. A name on this list is the beginning of a question, never the end of one.
The next step is never to trade the list; it is to test it. Our Guidance Momentum screen shows which risers have management raising guidance behind them, and our Buy the Dip screen shows which of the fallers still generate the growth and cash that make a recovery plausible.
Today’s Winner Is Tomorrow’s Loser Often Enough
The movers list is the most honest picture of single-stock risk the market prints each day: the same volatility that makes the winners column also fills the losers column, and no one reliably knows which side a stock lands on next.
That is the case for owning a disciplined basket instead of chasing the tape. The Trefis High Quality (HQ) Portfolio holds roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Watch the movers for information; let the portfolio do the compounding.